AI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative

Arthur Claessens1,2, Alizée Simon2, Agathe Manchart2

  • 1Université de Lorraine, Nancy, France.

JMIR Cancer
|February 23, 2026
PubMed
Summary

Artificial intelligence (AI) significantly speeds up clinical trial screening for pancreatic cancer patients, showing high sensitivity and reducing assessment time from hours to minutes. This AI-driven approach promises to improve efficiency and reproducibility in trial matching.

Related Concept Videos